Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice.

about

Intermittent catheterisation after botulinum toxin injections: the time to reassess our practice.

Item

http://www.wikidata.org/entity/Q48012632

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intermittent catheterisation a ...... time to reassess our practice.

@en

Intermittent catheterisation a ...... time to reassess our practice.

@nl

type

Item

label

Intermittent catheterisation a ...... time to reassess our practice.

@en

Intermittent catheterisation a ...... time to reassess our practice.

@nl

prefLabel

Intermittent catheterisation a ...... time to reassess our practice.

@en

Intermittent catheterisation a ...... time to reassess our practice.

@nl

P1476

Intermittent catheterisation a ...... time to reassess our practice.

@en

P2093

James Malone-Lee

http://www.w3.org/2001/XMLSchema#string

Linda Collins

http://www.w3.org/2001/XMLSchema#string

Mandy Fader

http://www.w3.org/2001/XMLSchema#string

Sanchutha Sathiananthamoorthy

http://www.w3.org/2001/XMLSchema#string

P2860

Refractory idiopathic urge urinary incontinence and botulinum A injection.

Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder.

Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability.

Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).

Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.

Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life.

Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates.

Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study.

What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.

P2888

s00192-017-3271-1

P304

1351-1356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00192-017-3271-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James Malone-Lee

P577

2017-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28116467

http://www.w3.org/2001/XMLSchema#string